(Updated - January 5, 2021 4:22 PM EST)

(updating comment)Stifel analyst Benjamin Burnett initiates coverage on Neoleukin Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE